We provide consulting services to pharmaceutical and biotechnology companies for clinical development of treatments mainly in the areas of rheumatology and autoimmune diseases.
The pharmaceutical industry faces increasing challenges.
Competition, regulatory requirements, and costs have increased, while the rate of new products coming to market has decreased.
Problems in clinical development include:
- Choosing the wrong indication